These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2020-002011-21 Bicentric, phase 2, randomized, open-label study to evaluate the efficacy and safety of maraviroc associated with standard treatment in hospitalized patients with pulmonary SARS-CoV-2 infection (COVID... not-yet-due
Ongoing 2020-004279-42 Standard vs High PROphylactic doses or anticoagulation in patients with high risk of THROMbosis admitted with COVID-19 pneumonia Ensayo Clínico que evalúa la tromboprofilaxis óptima y las estrategi... not-yet-due
Ongoing 2021-001028-16 DEXamethasone EARLY administration in hospitalized patients with Covid-19 pneumonia and high risk of developing acute respiratory distress syndrome Administración precoz de dexametasona en paciente... not-yet-due
Ongoing 2021-001416-29 EARLY TREATMENT STRATEGY WITH HIGH-DOSE VERSUS STANDARD-DOSE DEXAMETHASONE IN PATIENTS WITH SARS-COV-2 PNEUMONIA (COVID-19). ESTRATEGIA DE TRATAMIENTO PRECOZ CON DEXAMETASONA A DOSIS ALTAS FRENTE ... not-yet-due